drugset / Trial / NCT03779061

Study of Remimazolam Tosilate in Patients Undergoing Colonoscopy

NCT03779061

Phase 3 Completed 388 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupDouble-blindOther

Summary

The purpose of this study is to evaluate the safety and efficacy of the sedation for Remimazolam or Propofol in patients undergoing colonoscopy.

Timeline

Start
2018-06-28
Primary completion
2018-09-20
Completion
2018-09-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule
Subject Remimazolam Small molecule

Indications

No indication recorded.